For Healthcare bankers, I was looking through comparable companies and noticed something a bit strange - it seems that generic OTC drug manufacturers trade at a higher multiple than generic Rx drug manufacturers. I know that there is tough competition in the generics Rx space, but why not the same discount to OTC? Is there something about OTC that protects them from that steep competition? Thank you!
Only allow Certified Users to respond:
